Feed 6814.TWO
68
Lukas Biomedical Inc.
6814.TWO · TWO
$23.00 -4.56% (-$1.10)
1M -4.74%
Market Cap $963.1M
P/E Ratio -
Div. Yield -
ROE 27.87%
Valuation
40 /100
Fair P/S 5.37x
P/B 4.01x
P/E N/A
Growth
12 /100
Declining Rev. growth 0.96%
Book val. growth 9.82%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 53.31%
Net margin 47.71%
FCF margin 38.97%
Quality
5 /100
Poor ROIC 20.75%
ROE 27.87%
Asset turnover 0.42x
Debt
39 /100
Moderate Debt/Equity 0.65x
Current ratio 0.80x
Int. coverage -25.28x
Stability
25 /100
Unstable Beta 0.12x
Rev. volatility 22.42%
Profitable years 0
Vprašajte StockBota o 6814.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chaoan Liu
Employees
87
Headquarters
New Taipei